London-headquartered Apax Partners has sold its majority stake in Germany-based central nervous system (CNS) pharmaceutical products producer Neuraxpharm in an SBO to Permira.
London-headquartered Apax Partners has sold its majority stake in Germany-based central nervous system (CNS) pharmaceutical products producer Neuraxpharm in an SBO to Permira.